Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Surgical Science Sweden AB (publ) SUSRF

Full chart Compare
Set alert

Price alert · SUSRF

All alert types
5.48 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

Day range unavailable

2.84 52-week range 8.58
YTD
+60.56%
1 year
-35.96%

Financial health

Altman Z-Score

4.67 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 24.4×
FY 2016: 554×FY 2017: -955×FY 2018: -655×FY 2019: 292×FY 2020: 256×FY 2021: 142×FY 2022: 45.4×FY 2023: 26.0×FY 2024: 62.3×FY 2025: 24.4×
FY 2016 5y median 45.4× FY 2025
P/S 1.6×
FY 2016: 35.2×FY 2017: 38.2×FY 2018: 46.1×FY 2019: 36.5×FY 2020: 37.8×FY 2021: 33.5×FY 2022: 10.6×FY 2023: 6.9×FY 2024: 9.3×FY 2025: 1.6×
FY 2016 5y median 9.3× FY 2025
P/B 0.4×
FY 2016: 81.5×FY 2017: 25.9×FY 2018: 38.1×FY 2019: 9.2×FY 2020: 9.3×FY 2021: 3.4×FY 2022: 2.0×FY 2023: 1.4×FY 2024: 1.7×FY 2025: 0.4×
FY 2016 5y median 1.7× FY 2025
P/FCF 23.6×
FY 2016: 1074×FY 2017: -530×FY 2018: -1721×FY 2019: 80.1×FY 2020: 273×FY 2021: 497×FY 2022: 89.9×FY 2023: 31.3×FY 2024: 91.4×FY 2025: 23.6×
FY 2016 5y median 89.9× FY 2025
EV/EBITDA 5.2×
FY 2016: 216×FY 2017: 347×FY 2018: 494×FY 2019: 120×FY 2020: 105×FY 2021: 98.0×FY 2022: 29.1×FY 2023: 22.2×FY 2024: 35.6×FY 2025: 5.2×
FY 2016 5y median 29.1× FY 2025
EV/Sales 1.0×
FY 2016: 35.7×FY 2017: 37.6×FY 2018: 45.6×FY 2019: 35.8×FY 2020: 37.0×FY 2021: 32.7×FY 2022: 10.1×FY 2023: 6.2×FY 2024: 8.2×FY 2025: 1.0×
FY 2016 5y median 8.2× FY 2025
FCF Yield 4.2%
FY 2016: 0.1%FY 2017: -0.2%FY 2018: -0.1%FY 2019: 1.2%FY 2020: 0.4%FY 2021: 0.2%FY 2022: 1.1%FY 2023: 3.2%FY 2024: 1.1%FY 2025: 4.2%
FY 2016 5y median 1.1% FY 2025

Profitability

Gross Margin 58.1%
FY 2016: 112.2%FY 2017: 107.1%FY 2018: 109.5%FY 2019: 82.3%FY 2020: 84.3%FY 2021: 72.5%FY 2022: 66.2%FY 2023: 69.4%FY 2024: 67.6%FY 2025: 58.1%
FY 2016 5y median 67.6% FY 2025
Operating Margin 11.0%
FY 2016: -0.4%FY 2017: -6.4%FY 2018: -6.2%FY 2019: 15.0%FY 2020: 19.1%FY 2021: 24.2%FY 2022: 20.3%FY 2023: 21.4%FY 2024: 16.3%FY 2025: 11.0%
FY 2016 5y median 20.3% FY 2025
Net Margin 6.7%
FY 2016: 6.4%FY 2017: -3.9%FY 2018: -6.9%FY 2019: 12.4%FY 2020: 14.9%FY 2021: 23.5%FY 2022: 23.4%FY 2023: 26.5%FY 2024: 14.9%FY 2025: 6.7%
FY 2016 5y median 23.4% FY 2025
ROE 1.6%
FY 2016: 14.7%FY 2017: -2.6%FY 2018: -5.7%FY 2019: 3.1%FY 2020: 3.7%FY 2021: 2.4%FY 2022: 4.4%FY 2023: 5.4%FY 2024: 2.7%FY 2025: 1.6%
FY 2016 5y median 2.7% FY 2025
ROIC 1.7%
FY 2016: 2.5%FY 2017: -2.4%FY 2018: -4.9%FY 2019: 3.0%FY 2020: 3.6%FY 2021: 2.4%FY 2022: 3.4%FY 2023: 3.7%FY 2024: 2.4%FY 2025: 1.7%
FY 2016 5y median 2.4% FY 2025
ROA 1.4%
FY 2016: 5.2%FY 2017: -2.3%FY 2018: -4.5%FY 2019: 2.8%FY 2020: 3.3%FY 2021: 2.2%FY 2022: 4.0%FY 2023: 5.0%FY 2024: 2.4%FY 2025: 1.4%
FY 2016 5y median 2.4% FY 2025

Growth (YoY)

Revenue 12.0%
FY 2016: 12.4%FY 2017: 11.9%FY 2018: 13.3%FY 2019: 54.5%FY 2020: 3.2%FY 2021: 250.0%FY 2022: 118.8%FY 2023: 10.0%FY 2024: 0.1%FY 2025: 12.0%
FY 2016 FY 2025
Operating Income -24.7%
FY 2016: -111.1%FY 2017: -1767.5%FY 2018: -8.9%FY 2019: 473.0%FY 2020: 31.6%FY 2021: 344.3%FY 2022: 83.1%FY 2023: 16.4%FY 2024: -23.7%FY 2025: -24.7%
FY 2016 FY 2025
EPS (diluted) -50.0%
FY 2016: 249.5%FY 2017: -152.2%FY 2018: -50.0%FY 2019: 338.9%FY 2020: 4.7%FY 2021: 348.9%FY 2022: 82.7%FY 2023: 24.4%FY 2024: -43.8%FY 2025: -50.0%
FY 2016 FY 2025
Free Cash Flow -24.2%
FY 2016: 312.5%FY 2017: -345.8%FY 2018: 57.9%FY 2019: 2731.4%FY 2020: -68.6%FY 2021: 70.0%FY 2022: 284.3%FY 2023: 104.5%FY 2024: -53.8%FY 2025: -24.2%
FY 2016 FY 2025

Financial Health

Current Ratio 4.1×
FY 2016: 1.2×FY 2017: 5.6×FY 2018: 3.8×FY 2019: 2.8×FY 2020: 4.3×FY 2021: 2.7×FY 2022: 2.7×FY 2023: 4.2×FY 2024: 2.8×FY 2025: 4.1×
FY 2016 5y median 2.8× FY 2025
Quick Ratio 3.4×
FY 2016: 1.0×FY 2017: 4.8×FY 2018: 3.5×FY 2019: 2.7×FY 2020: 3.9×FY 2021: 2.2×FY 2022: 2.3×FY 2023: 3.6×FY 2024: 2.4×FY 2025: 3.4×
FY 2016 5y median 2.4× FY 2025
Debt / Equity 0.0×
FY 2016: 1.3×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -3.2×
FY 2016: 2.8×FY 2017: -5.7×FY 2018: -5.6×FY 2019: -2.2×FY 2020: -2.3×FY 2021: -2.5×FY 2022: -1.5×FY 2023: -2.4×FY 2024: -4.4×FY 2025: -3.2×
FY 2016 5y median -2.5× FY 2025
Interest Coverage 0.0×
FY 2016: -0.8×FY 2017: -20.9×FY 2018: -581×FY 2019: 0.0×FY 2020: 37.5×FY 2021: 3.9×FY 2022: 125×FY 2023: 12.6×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 3.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31